Results 91 to 100 of about 79,732 (230)

Phenytoin-induced gingival overgrowth

Cleveland Clinic Journal of Medicine, 2022
Mitesh, Karn, Ranjan, Sah, Shabal, Sapkota   +2 more
openaire   +2 more sources

Differential Diagnosis Performance of ChatGPT in Oral and Maxillofacial Pathology

Oral Diseases, EarlyView.
ABSTRACT Objective To evaluate ChatGPT (GPT‐5.1) for ranked differential diagnoses in oral and maxillofacial pathology, assess image effects on diagnostic performance and examine output stability across repeated runs. Methods This retrospective diagnostic accuracy study included 160 biopsy‐confirmed cases.
Sohaib Shujaat, Marryam Riaz, Jawaher Mohammed Alsubaie, Aljwhrah Abdulaziz Almuammar, Arun Pillai, Abdulmohsen Alfadley, Ali Anwar Aboalela   +6 more
wiley   +1 more source

Gingival Changes after Immunosuppressive Therapy II.

Česká Stomatologie a Praktické Zubní Lékařství, 2005
There are emerging new problems associated with medication side effect with development of therapeutic modalities of current medical approaches. Some of these, such as Cyclosporin A (CsA), anticonvulsants, calcium channel blockers are associated with ...
A. Fassmann, P. Augustín, J. Slapnička
doaj  

Efficacy of AZM therapy in patients with gingival overgrowth induced by Cyclosporine A: a systematic review

BMC Oral Health, 2008
Background In daily clinical practice of a dental department it's common to find gingival overgrowth (GO) in periodontal patients under treatment with Cyclosporine A (CsA).
Deli Giorgio, Macrì Ludovica, Gualano Maria, Crea Alessandro, Vittorini Gianluca, Clementini Marco, La Torre Giuseppe   +6 more
doaj   +1 more source

Osteosarcoma of the Jaws in Latin America: A Retrospective Multicenter Series of 119 Cases

Oral Diseases, EarlyView.
ABSTRACT Objective Epidemiological and survival data on osteosarcoma of the jaws (OSJ) in Latin America remain scarce. We characterized the clinicopathological, radiographic, treatment‐related, and survival features of OSJ in Latin America. Methods This multicenter case series involved 22 institutions from Brazil, Chile, Argentina, Colombia, Venezuela,
Victor Zanetti Drumond, José Alcides Almeida de Arruda, Mariana Villaroel‐Dorrego, Leonardo Amaral Dos Reis, Gerhilde Callou Sampaio, Lauren Frenzel Schuch, Carolina Louzada Menna‐Barreto, Manoela Domingues Martins, Paula Celeghini Goulart, Guilherme Gomes Souza, Fabrício Tinôco Alvim de Souza, Warley Oliveira Silva, Karina Cordero‐Torres, Rolando Morales‐Espinosa, René Panico, Gerardo Gilligan, Federico Garola, Carlos Marcelo Cerullo, Nicolás Leonardi, Javier Giménez, Verónica Flück, Ángeles Castrillo, Laura Leguina, Claudia Patricia Peña‐Vega, Juan Pablo Rodríguez‐Mora, Kallana Mezzomo‐Faccin, Ricardo Luiz Cavalcanti de Albuquerque‐Junior, Rogério Gondak, Mônica Simões Israel, Pollianna Muniz Alves, Amanda Claudino Gomes, Cassiano Francisco Weege Nonaka, Michel Campos Ribeiro, Elismauro Francisco de Mendonça, Victor Hugo Lopes de Oliveira Moreira, Diego Antônio Costa Arantes, Israel Leal Cavalcante, Eveline Turatti, Roberta Barroso Cavalcante, Giovanna Tacchi, Ana Paula Neutzling Gomes, Karen Müller Bubolz, Adriana Etges, María Natalia González Umpiérrez, Natalia Fernanda Tancredi Cueto, Aurita Verónica Beovide‐Cortegoso, Ronell Bologna‐Molina, Saray Aranda‐Romo, Francisco Javier Tejeda‐Nava, Lucas Guimarães Abreu, Bruno Augusto Benevenuto de Andrade, Ricardo Alves Mesquita   +51 more
wiley   +1 more source

A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi, Katherine Mathes, Sathya Kosuri, Amulya Gupta, Neil Phillips, Rhea Pimentel, Martin Emert, Siva Soma, Rigoberto Ramirez, Raghuveer Dendi, Madhu Reddy, Seth H. Sheldon, Wissam El Atrouni, Larry M. Baddour, Amit Noheria   +14 more
wiley   +1 more source

Amlodipine-induced gingival overgrowth: a case report

, 2007
Gingival overgrowth is frequently observed in patients taking certain drugs such as calcium channel blockers, anticonvulsants and immunosuppressant. This can have a significant effect on the quality of life as well as increasing the oral bacterial load ...
Husna Zayadi
core  

Upregulation of embryonic stem cell marker Nanog in human gingival fibroblasts stimulated with cyclosporine A: An in vitro study

Journal of Dental Sciences, 2017
Background/purpose: Gingival overgrowth is a common side effect of medication with the immunosuppressant cyclosporine A (CsA). This study proposed to verify whether Nanog, an embryonic stem cell marker, contributes to gingival overgrowth stimulated with ...
Cheng-Chia Yu, Ni-Yu Su, Chia-Ming Liu, Li-Chiu Yang, Chung-Hung Tsai, Yu-Chao Chang   +5 more
doaj   +1 more source

Amlodipine induced Gingival Overgrowth

Journal of Nepalese Society of Periodontology and Oral Implantology, 2018
Gingival overgrowth caused by drug is a well-documented unwanted side effect and mostly caused by Nifedipine. Newer generation calcium channel blocker, amlodipine, has been used with the increasing frequency to overcome the adverse effect of first and second generation dihydropyridine derivatives of Calcium Chanel Blocker.
Surendra Man Shrestha, Kripa Shahi, Deepa Aryal   +2 more
openaire   +2 more sources

Epithelial to mesenchymal transition in human gingival overgrowth [PDF]

, 2011
Thesis (MSD) --Boston University, Henry M. Goldman School of Dental Medicine, 2011 (Department of Oral Biology and Periodontology).Includes bibliographic references: leaves 66-78.Drug induced gingival overgrowth is a side-effect and unwanted outcome of ...
Kim, Yong Soo
core   +1 more source